Comparison of dantrolene sodium and diazepam in the treatment of spasticity.
- 1 April 1976
- journal article
- clinical trial
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 39 (4) , 350-356
- https://doi.org/10.1136/jnnp.39.4.350
Abstract
The effects of dantrolene sodium and diazepam were compared in a double crossover study of 42 patients with spasticity due to stable multiple sclerosis. Both drugs reduced the findings of spasticity, clonus, and hyperreflexia, and the complaints of muscle stiffness and cramping. Each drug had different side effects which suggest indications and contraindications for its use in spastic patients.Keywords
This publication has 25 references indexed in Scilit:
- A DOUBLE-BLIND TRIAL WITH BACLOFEN (LIORESAL®) AND DIAZEPAM IN SPASTICITY DUE TO MULTIPLE SCLEROSISActa Neurologica Scandinavica, 2009
- THE MODE OF ACTION OF THE GABA DERIVATIVE BACLOFEN IN HUMAN SPASTICITYActa Neurologica Scandinavica, 2009
- THE EFFECT OF DANTRIUM®* ON SPASTICITY IN MULTIPLE SCLEROSISActa Neurologica Scandinavica, 2009
- DRUGS IN THE MANAGEMENT OF SPASTICITYDevelopmental Medicine and Child Neurology, 2008
- A double blind, cross-over trial of valium in the treatment of spasticitySpinal Cord, 1972
- The Effects of Dantrolene Sodium on Spasticity and Motor Performance in HemiplegiaSouthern Medical Journal, 1971
- GABA DERIVATIVE IN SPASTICITY (β-(4-Chlorophenyl)-γ-Aminobutyric Acid, Ciba 34.647-Bα)Acta Neurologica Scandinavica, 1970
- An assessment of the reliability of three methods used in evaluating the status of multiple sclerosis patientsJournal of Chronic Diseases, 1969
- Quantitative clinical neurological testing—IIJournal of Chronic Diseases, 1965
- QUANTITATIVE CLINICAL NEUROLOGICAL TESTING. I. A STUDY OF A BATTERY OF TESTS DESIGNED TO EVALUATE IN PART THE NEUROLOGICAL FUNCTION OF PATIENTS WITH MULTIPLE SCLEROSIS AND ITS USE IN A THERAPEUTIC TRIAL*Annals of the New York Academy of Sciences, 1965